CORe Initiative Looks to Transform Cancer Research Through Increased Diversity and Data Sharing
March 5th 2024The CORe initiative is aimed at promoting inclusivity, reducing startup time for clinical trials, and facilitating data sharing to address recruitment and retention challenges in cancer research at community oncology sites.
Read More
Expert: Updates for Zotatifin ER+/HER2- Breast Cancer Treatment
December 15th 2023Douglas Warner, MD, chief medical officer at eFFECTOR, provides a comprehensive overview of zotatifin and its current status in a Phase 1/2 dose escalation and expansion study, with a focus on ER+/HER2- breast cancer.
Watch
Expert Discusses Navigating Toxicities, Understanding Antibody-Drug Conjugate Adverse Events
December 14th 2023Heather McArthur, MD, clinical director of breast oncology at UT Southwestern Medical Center, discusses the toxicities associated with antibody-drug conjugates (ADCs) used in breast cancer treatment at the 2023 San Antonio Breast Cancer Symposium.
Watch